Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/38853
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kurz, Xavier | - |
dc.contributor.author | Cohet, Catherine | - |
dc.contributor.author | Quinten, Chantal | - |
dc.contributor.author | MOLENBERGHS, Geert | - |
dc.contributor.author | HENS, Niel | - |
dc.contributor.author | ABRAMS, Steven | - |
dc.contributor.author | WILLEM, Lander | - |
dc.contributor.author | CREVECOEUR, Jonas | - |
dc.contributor.author | LOEDY, Neil | - |
dc.contributor.author | VERBEECK, Johan | - |
dc.date.accessioned | 2022-11-08T09:11:30Z | - |
dc.date.available | 2022-11-08T09:11:30Z | - |
dc.date.issued | 2022 | - |
dc.date.submitted | 2022-11-03T17:24:17Z | - |
dc.identifier.citation | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 31 , p. 135 -136 | - |
dc.identifier.uri | http://hdl.handle.net/1942/38853 | - |
dc.language.iso | en | - |
dc.publisher | WILEY | - |
dc.title | Benefit risk contextualization of COVID-19 vaccines in the EU | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | 136 | - |
dc.identifier.spage | 135 | - |
dc.identifier.volume | 31 | - |
local.format.pages | 2 | - |
local.bibliographicCitation.jcat | M | - |
local.publisher.place | 111 RIVER ST, HOBOKEN 07030-5774, NJ USA | - |
local.type.refereed | Refereed | - |
local.type.specified | Meeting Abstract | - |
dc.identifier.isi | 000859084400264 | - |
local.provider.type | wosris | - |
local.description.affiliation | [Kurz, Xavier; Cohet, Catherine; Quinten, Chantal] European Med Agcy, Amsterdam, Netherlands. | - |
local.description.affiliation | [Molenberghs, Geert; Hens, Niel; Abrams, Steven; Crevecoeur, Jonas; Loedy, Neilshan; Verbeeck, Johan] Univ Hasselt, Hasselt, Belgium. | - |
local.description.affiliation | [Willem, Lander] Univ Antwerp, Antwerp, Belgium. | - |
local.uhasselt.international | yes | - |
item.fulltext | With Fulltext | - |
item.accessRights | Open Access | - |
item.fullcitation | Kurz, Xavier; Cohet, Catherine; Quinten, Chantal; MOLENBERGHS, Geert; HENS, Niel; ABRAMS, Steven; WILLEM, Lander; CREVECOEUR, Jonas; LOEDY, Neil & VERBEECK, Johan (2022) Benefit risk contextualization of COVID-19 vaccines in the EU. In: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 31 , p. 135 -136. | - |
item.contributor | Kurz, Xavier | - |
item.contributor | Cohet, Catherine | - |
item.contributor | Quinten, Chantal | - |
item.contributor | MOLENBERGHS, Geert | - |
item.contributor | HENS, Niel | - |
item.contributor | ABRAMS, Steven | - |
item.contributor | WILLEM, Lander | - |
item.contributor | CREVECOEUR, Jonas | - |
item.contributor | LOEDY, Neil | - |
item.contributor | VERBEECK, Johan | - |
crisitem.journal.issn | 1053-8569 | - |
crisitem.journal.eissn | 1099-1557 | - |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Abstract.pdf | Peer-reviewed author version | 85.56 kB | Adobe PDF | View/Open |
133.pdf Restricted Access | Published version | 163.42 kB | Adobe PDF | View/Open Request a copy |
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.